Joseph Brito III, MD
Assistant Professor of Urology
Research & Publications
Biography
News
Selected Publications
- PT417 National variation in lymph node dissection and pathological yield at the time of radical cystectomyAbello A, Brito J, Sprenkle P, Kenney P, Renzulli J, Leapman M. PT417 National variation in lymph node dissection and pathological yield at the time of radical cystectomy. European Urology Open Science 2020, 19: e2286. DOI: 10.1016/s2666-1683(20)34151-3.
- MP61-12 NATIONAL VARIATION IN LYMPH NODE DISSECTION AND PATHOLOGICAL YIELD AT THE TIME OF RADICAL CYSTECTOMYAbello* A, Nawaf C, Brito J, Sprenkle P, Kenney P, Renzulli J, Leapman M. MP61-12 NATIONAL VARIATION IN LYMPH NODE DISSECTION AND PATHOLOGICAL YIELD AT THE TIME OF RADICAL CYSTECTOMY. Journal Of Urology 2020, 203: e939-e940. DOI: 10.1097/ju.0000000000000936.012.
- MP18-20 EX-VIVO TARGETING OF UPPER TRACT UROTHELIAL CARCINOMA USING A NOVEL PHLIP – ICG CONSTRUCTBrito J, Golijanin B, Pereira J, Amin A, Golijanin D. MP18-20 EX-VIVO TARGETING OF UPPER TRACT UROTHELIAL CARCINOMA USING A NOVEL PHLIP – ICG CONSTRUCT. Journal Of Urology 2018, 199: e221. DOI: 10.1016/j.juro.2018.02.596.
- 69 Novel ex vivo endoscopic near infrared fluorescence imaging method using pHLIP®/ICG in patients undergoing radical cystectomy for urothelial carcinoma of the bladderBrito J, Golijanin B, Tran T, Moshnikova A, Gershman B, Engelman D, Reshetnyak Y, Andreev O, Amin A, Golijanin D. 69 Novel ex vivo endoscopic near infrared fluorescence imaging method using pHLIP®/ICG in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. European Urology Open Science 2017, 16: e116-e117. DOI: 10.1016/s1569-9056(17)30136-7.
- Presence and percentage of type 2 papillary RCC in mixed (type 1 and type 2) papillary renal cell carcinoma does not portend worse prognosis in patients treated by partial/radical nephrectomy in non-metastatic disease.Leone A, Diorio G, Brito J, Zargar K, Pareek G, Renzulli J, Dickinson S, Amin A, Sexton W, Spiess P, Poch M, Golijanin D. Presence and percentage of type 2 papillary RCC in mixed (type 1 and type 2) papillary renal cell carcinoma does not portend worse prognosis in patients treated by partial/radical nephrectomy in non-metastatic disease. Journal Of Clinical Oncology 2016, 34: e16126-e16126. DOI: 10.1200/jco.2016.34.15_suppl.e16126.
- PD03-05 UPSTAGING IN RADICAL PROSTATECTOMY IN THE POST-PSA ERA: AN EFFECT OF DELAYED DIAGNOSIS OR BETTER PATIENT SELECTION?Rotker K, Brito J, Edmund L, Matoso A, Renzulli J. PD03-05 UPSTAGING IN RADICAL PROSTATECTOMY IN THE POST-PSA ERA: AN EFFECT OF DELAYED DIAGNOSIS OR BETTER PATIENT SELECTION? Journal Of Urology 2016, 195: e57-e58. DOI: 10.1016/j.juro.2016.02.2093.
- MP36-18 HIGH-RISK HPV SUBTYPES IN SQUAMOUS CELL CARCINOMA OF THE SCROTUMBrito J, Rotker K, Lepe M, Quddus M, Manna P, Epstein J, Matoso A, Renzulli J. MP36-18 HIGH-RISK HPV SUBTYPES IN SQUAMOUS CELL CARCINOMA OF THE SCROTUM. Journal Of Urology 2016, 195: e496. DOI: 10.1016/j.juro.2016.02.1652.
- MP49-20 EX VIVO FLUORESCENCE IMAGING OF UROTHELIAL CARCINOMA IN HUMAN BLADDERS TARGETED BY ICG-PHLIPBrito J, Golijanin J, Tran T, Andreev G, Reshetnyak Y, Amin A, Golijanin D. MP49-20 EX VIVO FLUORESCENCE IMAGING OF UROTHELIAL CARCINOMA IN HUMAN BLADDERS TARGETED BY ICG-PHLIP. Journal Of Urology 2016, 195: e671-e672. DOI: 10.1016/j.juro.2016.02.433.
- MP57-16 ANTIPLATELET/ANTICOAGULATION THERAPY DOES NOT INCREASE IMMEDIATE COMPLICATIONS IN PATIENTS UNDERGOING ROBOTIC PARTIAL NEPHRECTOMY (RPN)Leone A, Turini G, Brito J, Tran T, Renzulli J, Pareek G, Golijanin D. MP57-16 ANTIPLATELET/ANTICOAGULATION THERAPY DOES NOT INCREASE IMMEDIATE COMPLICATIONS IN PATIENTS UNDERGOING ROBOTIC PARTIAL NEPHRECTOMY (RPN). Journal Of Urology 2015, 193: e695-e696. DOI: 10.1016/j.juro.2015.02.2004.